Archive · 22 Jul 2026
Delhi HC Examines PIL on HPV Vaccination Programme
The Delhi High Court is looking into a complaint about the government's plan to give HPV vaccines to teenage girls.
The complaint says the vaccines are being given without proper permission from parents and without enough information about their safety.
The court wants the government to provide data on any bad reactions to the vaccine.
The complaint also mentions some girls who had serious health problems after getting the vaccine.
The court will decide if the vaccination programme should continue as it is or if changes need to be made.
The Delhi High Court agreed to examine a PIL challenging the HPV vaccination programme for adolescent girls.
The court directed the Union government to provide data on adverse events following HPV vaccination.
The petition alleges that the vaccine is being administered without proper informed consent or prior approval from parents.
The petition cites cases of severe neurological symptoms in girls after receiving the HPV vaccine.
The petition argues that compulsory vaccination violates the constitutional rights of bodily integrity and personal autonomy.
- Who
- Delhi High Court, Union Government, Petitioners (Rohit Kumar)
- What
- Examination of a PIL challenging the HPV vaccination programme for adolescent girls
- When
- Wednesday (specific date not mentioned)
- Where
- Delhi High Court, New Delhi
- Why
- To address concerns over the HPV vaccination programme, including informed consent, safety, and efficacy
Petitioners
Government and Health Authorities
Informed Consent
Petitioners
The petitioners argue that the HPV vaccine is being administered without proper informed consent or prior approval from parents, violating the constitutional rights of young girls.
Government and Health Authorities
The government and health authorities maintain that the vaccination programme is implemented with necessary protocols and consent procedures.
Safety and Efficacy
Petitioners
The petitioners question the safety and efficacy of the HPV vaccine, citing adverse events and lack of credible data.
Government and Health Authorities
The government and health authorities assert that the vaccine is safe and effective, backed by scientific evidence and international health standards.
- Court
- Delhi High Court
- Petitioners
- Rohit Kumar (Advocate)
- Respondents
- Union Government
- Vaccine in Question
- Gardasil (HPV Vaccine)
- Target Group
- Adolescent girls aged around 14 years
- Programme
- Universal Immunisation Programme (UIP)
- Key Concerns
- Informed consent, safety, efficacy, and public health priorities